Resmed Inc (RMD) Stock Price, Quote & News

Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry,...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 858-836-5000

Website: www.resmed.com

Address:

9001 Spectrum Center Boulevard, San Diego, United States

OfficialStocktwitsUser May. 7 at 11:33 AM

$RMD RSI: 33.11, MACD: -6.0446 Vol: 8.19, MA20: 220.25, MA50: 230.02 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

OfficialStocktwitsUser May. 7 at 12:22 AM

0 · Reply

BillionerOfKing May. 6 at 10:27 PM

$RMD Current Stock Price: $209.60 Contracts to trade: $210.0 RMD May 15 2026 Call Entry: $3.40 Exit: $4.58 ROI: 35% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

CapitalMonk May. 5 at 12:28 AM

$RMD Price: $209.43 (+2.15%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±0.76% RSI: 27.5 | Momentum: Moderate Volume: +60.4% vs avg Volatility: 1.64% Support: $198.64 | Resistance: $234.91 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

Washingtonstate May. 1 at 6:47 PM

$RMD

1 · Reply

macdub8 May. 1 at 3:26 PM

$IXHL another 1.5b wiped off $RMD market cap in the space of 1.5hours today Anyway this is going to be the last post about RMD and IXHL. I truly believe that bigger things are awaiting IXHL.

2 · Reply

thefourpercent May. 1 at 3:15 PM

$RMD eyes are here too, waiting

0 · Reply

Anonymouspapertrader Apr. 30 at 10:29 PM

$RMD 100sma still in trend, 200sma still not in the trend, so it looks to be a test of the 100 here.

0 · Reply

Mamalama Apr. 30 at 9:39 PM

$IXHL $RMD and that’s a no

0 · Reply

macdub8 Apr. 30 at 9:17 PM

$RMD $IXHL RMD is absolutely nose-diving in AH. Nearly 2b of its market cap wiped in an hour.

3 · Reply

ResMed price target lowered to $225 from $254 at Baird

2026-05-01T11:18:33.000Z - 6 days ago

ResMed price target lowered to $235 from $265 at Stifel

Apr 30, 2026, 6:21 PM EDT - 6 days ago

ResMed beats quarterly profit estimates, names new CFO

2026-04-30T21:15:22.000Z - 6 days ago

ResMed CFO Brett Sandercock to retire, Aaron Bloomer to succeed

Apr 30, 2026, 4:30 PM EDT - 7 days ago

ResMed Earnings Call Transcript: Q3 2026

2026-04-30T20:20:36.000Z - 7 days ago

ResMed reports Q3 EPS $2.86, consensus $2.72

Apr 30, 2026, 4:10 PM EDT - 7 days ago

Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor

Apr 30, 2026, 4:05 PM EDT - 7 days ago

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026

2026-04-27T10:25:52.000Z - 10 days ago

ResMed price target lowered to $290 from $302 at KeyBanc

2026-04-15T15:25:36.000Z - 22 days ago

ResMed initiated with an Overweight at JPMorgan

2026-04-13T14:45:22.000Z - 24 days ago

ResMed price target lowered to $255 from $300 at Evercore ISI

2026-04-09T10:35:37.000Z - 4 weeks ago

ResMed price target lowered to $340 from $345 at Citi

Apr 1, 2026, 4:05 PM EDT - 5 weeks ago

Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026

Mar 3, 2026, 3:00 AM EST - 2 months ago

Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Feb 25, 2026, 12:56 PM EST - 2 months ago

ResMed At $250: Missed Opportunity Or A Trap In The Making?

2026-02-24T14:11:51.000Z - 2 months ago

ResMed opens new distribution center in Greenwood, Indiana

Feb 24, 2026, 9:00 AM EST - 2 months ago

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

Feb 3, 2026, 12:29 AM EST - 3 months ago

Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge

NVO

2026-02-02T11:56:46.000Z - 3 months ago

ResMed price target raised to $345 from $330 at Citi

2026-01-30T12:55:16.000Z - 3 months ago

ResMed price target raised to $314 from $311 at RBC Capital

2026-01-30T12:46:57.000Z - 3 months ago

ResMed price target raised to $302 from $299 at KeyBanc

2026-01-30T12:46:41.000Z - 3 months ago

ResMed price target raised to $265 from $260 at Stifel

2026-01-30T12:40:09.000Z - 3 months ago

ResMed price target raised to $281 from $275 at Baird

2026-01-30T12:05:31.000Z - 3 months ago

ResMed price target raised to $275 from $270 at Piper Sandler

Jan 29, 2026, 4:41 PM EST - 3 months ago

ResMed beats quarterly profit estimates on strong demand for its sleep devices

Jan 29, 2026, 4:30 PM EST - 3 months ago

ResMed Earnings Call Transcript: Q2 2026

2026-01-29T21:26:52.000Z - 3 months ago

ResMed reports Q2 EPS $2.81, consensus $2.72

Jan 29, 2026, 4:05 PM EST - 3 months ago

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026

Jan 12, 2026, 1:30 PM EST - 4 months ago

ResMed Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 8, 2026, 4:05 PM EST - 4 months ago

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

Dec 18, 2025, 4:05 PM EST - 4 months ago

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

2025-12-18T11:41:38.000Z - 5 months ago

ResMed price target lowered to $260 from $270 at Stifel

Dec 8, 2025, 9:00 AM EST - 5 months ago

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

Nov 24, 2025, 2:15 PM EST - 5 months ago

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

IDXX

Nov 19, 2025, 6:00 PM EST - 6 months ago

ResMed Transcript: AGM 2025

Oct 30, 2025, 4:30 PM EDT - 6 months ago

ResMed Earnings Call Transcript: Q1 2026

Oct 30, 2025, 4:05 PM EDT - 6 months ago

Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026

Oct 9, 2025, 4:05 PM EDT - 7 months ago

Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025

Sep 23, 2025, 8:20 AM EDT - 8 months ago

ResMed Transcript: Bank of America Global Healthcare Conference 2025

Sep 16, 2025, 4:05 PM EDT - 8 months ago

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

Sep 8, 2025, 9:00 PM EDT - 8 months ago

The sleep economy is 'having a moment', says medical equipment firm Resmed

Sep 3, 2025, 4:15 PM EDT - 8 months ago

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

Aug 27, 2025, 9:00 AM EDT - 9 months ago

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

Aug 18, 2025, 4:15 PM EDT - 9 months ago

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Jul 31, 2025, 4:53 PM EDT - 9 months ago

Resmed beats quarterly profit estimates on strong demand for sleep devices

Jul 31, 2025, 4:30 PM EDT - 10 months ago

ResMed Earnings Call Transcript: Q4 2025

Jul 31, 2025, 4:05 PM EDT - 10 months ago

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025

Jul 30, 2025, 6:08 AM EDT - 10 months ago

Spot Outliers Like ResMed Early with Money Flows

Jul 1, 2025, 4:05 PM EDT - 11 months ago

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

May 1, 2025, 9:00 AM EDT - 1 year ago

Resmed Acquires VirtuOx

Apr 23, 2025, 5:08 PM EDT - 1 year ago

ResMed slightly beats quarterly profit estimates on sleep devices demand

Apr 23, 2025, 4:30 PM EDT - 1 year ago

ResMed Earnings Call Transcript: Q3 2025

Apr 23, 2025, 4:05 PM EDT - 1 year ago

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Apr 21, 2025, 5:00 PM EDT - 1 year ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Apr 3, 2025, 9:00 AM EDT - 1 year ago

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

Apr 2, 2025, 4:05 PM EDT - 1 year ago

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Mar 19, 2025, 8:00 AM EDT - 1 year ago

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

Mar 11, 2025, 9:00 AM EDT - 1 year ago

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

Feb 26, 2025, 3:00 AM EST - 1 year ago

ResMed's Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Feb 11, 2025, 4:30 AM EST - 1 year ago

Jan De Witte joins GHO Capital as Operating Partner

IART

Jan 30, 2025, 5:21 PM EST - 1 year ago

ResMed beats quarterly profit estimates on demand for sleep disorder devices

Jan 30, 2025, 4:30 PM EST - 1 year ago

ResMed Earnings Call Transcript: Q2 2025

Jan 30, 2025, 4:05 PM EST - 1 year ago

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025

Jan 13, 2025, 6:00 PM EST - 1 year ago

ResMed Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 9, 2025, 4:05 PM EST - 1 year ago

ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025

Jan 6, 2025, 4:05 PM EST - 1 year ago

ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 23, 2024, 2:59 PM EST - 1 year ago

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

INSP LLY

Dec 4, 2024, 4:13 AM EST - 1 year ago

Canada Sleep Apnea Devices Market Research Report 2024: Opportunities and Forecasts to 2029 Featuring Braebon Medical, VitalAire, FPM Solutions, SomnoMed, and ResMed

Nov 12, 2024, 6:30 PM EST - 1 year ago

ResMed Transcript: UBS Global Healthcare Conference 2024

Nov 5, 2024, 4:05 PM EST - 1 year ago

ResMed Announces Participation in the UBS Global Healthcare Conference

Oct 29, 2024, 11:23 AM EDT - 1 year ago

ResMed CEO On Earnings, Sleep Apnea

Oct 24, 2024, 5:00 PM EDT - 1 year ago

ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices

Oct 24, 2024, 4:30 PM EDT - 1 year ago

ResMed Earnings Call Transcript: Q1 2025

Oct 3, 2024, 4:05 PM EDT - 1 year ago

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024

Sep 30, 2024, 4:05 PM EDT - 1 year ago

ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns

Sep 30, 2024, 1:00 PM EDT - 1 year ago

ResMed Transcript: Investor Day 2024

Sep 30, 2024, 9:48 AM EDT - 1 year ago

UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health

Sep 30, 2024, 9:23 AM EDT - 1 year ago

UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

Sep 30, 2024, 8:10 AM EDT - 1 year ago

ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

OfficialStocktwitsUser May. 7 at 11:33 AM

0 · Reply

OfficialStocktwitsUser May. 7 at 12:22 AM

0 · Reply

BillionerOfKing May. 6 at 10:27 PM

0 · Reply

CapitalMonk May. 5 at 12:28 AM

0 · Reply

Washingtonstate May. 1 at 6:47 PM

$RMD

1 · Reply

macdub8 May. 1 at 3:26 PM

$IXHL another 1.5b wiped off $RMD market cap in the space of 1.5hours today Anyway this is going to be the last post about RMD and IXHL. I truly believe that bigger things are awaiting IXHL.

2 · Reply

thefourpercent May. 1 at 3:15 PM

$RMD eyes are here too, waiting

0 · Reply

Anonymouspapertrader Apr. 30 at 10:29 PM

$RMD 100sma still in trend, 200sma still not in the trend, so it looks to be a test of the 100 here.

0 · Reply

Mamalama Apr. 30 at 9:39 PM

$IXHL $RMD and that’s a no

0 · Reply

macdub8 Apr. 30 at 9:17 PM

$RMD $IXHL RMD is absolutely nose-diving in AH. Nearly 2b of its market cap wiped in an hour.

3 · Reply

StocktwitsEarnings Apr. 30 at 8:14 PM

$RMD Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $2.74 up 10.04% YoY • Reported revenue of $1.43B up 10.81% YoY • As Resmed advances through the remainder of fiscal year 2026, the company remains focused on expanding access to care globally, scaling digital health capabilities, and delivering further strong, profitable growth.

0 · Reply

_Rocket Apr. 30 at 8:09 PM

$RMD $IXHL announce the buyout immediately you cucks. Nobody cares about how your quarter went. We want disclosure.

2 · Reply

J4y000 Apr. 30 at 8:03 PM

$RMD -> $IXHL

0 · Reply

Rvvrn9 Apr. 30 at 7:06 PM

$IXHL $RMD AH before EC

0 · Reply

DonCorleone77 Apr. 30 at 6:56 PM

$RBLX $RMD $MTZ $RDDT $DXCM Some notable companies reporting after the market close, with earnings consensus Estimates: - Apple (AAPL), consensus $1.95 - Amgen (AMGN), consensus $4.77 - SandDisk (SNDK), consensus $14.62 - Western Digital (WDC), consensus $2.40 - Stryker (SYK), consensus $2.98 - Roblox (RBLX), consensus (41c) - Resmed (RMD), consensus $2.80 - MasTec (MTZ), consensus 99c - Reddit (RDDT), consensus 57c - Dexcom (DXCM), consensus 47c - Twilio (TWLO), consensus $1.27 - First Solar (FSLR), consensus $3.03 - Rivian (RIVN), consensus (63c) - Atlassian (TEAM), consensus $1.33 - Illumina (ILMN), consensus $1.06 - Roku (ROKU), consensus 33c - Clorox (CLX), consensus $1.55 - Boston Beer (SAM), consensus $1.97 - Five9 (FIVN), consensus 68c.

0 · Reply

macdub8 Apr. 30 at 5:41 PM

$IXHL $RMD good time to regurgitate this from October 2025. A tuck in acquisition is exactly what IXHL would be..to its very core. Lets see

0 · Reply

Estimize Apr. 30 at 3:00 PM

$RMD reports after the close, Estimize Consensus -0.01 EPS and +3.39M Revs compared to WS http://www.estimize.com/rmd/fq3-2026?utm_content=

0 · Reply

Rasputi Apr. 30 at 1:06 PM

$IXHL $RMD one year ago, listen Mick Farrell about GOP and how his machines are the gold standard. Stock pumped till August then dramatically down since. We will see if his 100% bet on tuck-in tech/AI acquisition keep the road… Start the video at 2:04 https://www.youtube.com/watch?v=WOfr1jBSCXo

0 · Reply

J4y000 Apr. 30 at 12:36 PM

$RMD -> $IXHL One way or another RMD suffers if they don’t act soon and either BO or Partner.

0 · Reply

IldijanaMM Apr. 30 at 12:33 PM

$IXHL $RMD They need us! Just saying 😉

0 · Reply

stockro1 Apr. 30 at 12:25 PM

$IXHL $RMD earnings report today. Let’s see.

0 · Reply

Market Cap	30.28B
Revenue (ttm)	5.15B
Net Income (ttm)	1.40B
EPS (ttm)	N/A
PE Ratio	19.45
Forward PE	18.82
Profit Margin	27.22%
Debt to Equity Ratio	0.06

Volume	1,295,303
Avg Vol	1,142,140
Day's Range	N/A - N/A
Shares Out	145.68M
Stochastic %K	44%
Beta	0.84
Analysts	Sell
Price Target	$267.46